Skip navigation
Menu

Home About us Markets Services Projects News Work with us Contact us
 
Search



Browse

Projects

Buildings Industry Oil and gas Power Social development Transport Urban infrastructure Water and environment
Industry

General manufacturing Agro-based industry Chemicals and petrochemicals Development zones Pharmaceuticals and biotechnology Metals Synthetic fibres
 

Pharmaceuticals and biotechnology

Sandoz pharma plant


Sandoz, a wholly-owned subsidiary of Novartis-AG, has set up a pharmaceutical formulation facility at Kalwe, at the outskirts of Mumbai. Sandoz's first large scale facility in Asia was built at a cost of $13 million. The facility has been built to US and European standards and is dedicated to these markets.

Mott MacDonald was proud to be associated with this fast paced, ambitious project and provided basic engineering, detailed engineering and procurement assistance as well as inspection, construction supervision and project management services.

Mott MacDonald rendered Conceptual Design, Basic Engineering, Detailed Engineering, Construction Supervision, Inspection, Validation & Project Management Services to Oral Solid and Tablet Manufacturing Facility

New tablet manufacturing facility, Gujarat


The Brownfield project comprised of a new 13,000 TPA tablet manufacturing facility located at Jhagadia in the state of Gujarat. The project involved three production blocks comprising of 450 equipments, tank farms, warehouses, utility block and other associated amenities. The production plant involved process operations like reactions, fractional distillation, solvent recovery, synthesis with unit operations like pastillation and scrubbing. We provided detailed engineering and project management services for Astra Zeneca.

Present at our customers' meet in Bangalore (from left to right): D V Saraiya, Divisional Director, Mott MacDonald, Kevin Stovell, Regional Managing Director, Middle East & South Asia, Mott MacDonald, Mike Mungall, Head of Global Projects, Astra Zenecea, Neil Crossan, Project Director, Global Engineering, Astra Zenecea and Mukesh Jain, Director, Mott MacDonald

New API facility, Matoda


Intas has set up a new API plant for production of bulk drugs with USFDA complaints. The plant would produce metaprolol, pregabaline, rabeprazole, aripiprazole and temisartan. We provided complete basic and detailed engineering for Intas Pharmaceuticals Limited.

Wockhardt biotech facility


Wockhardt, a pharmaceuticals major and amongst the 50 most valuable companies in India, has set up a 28000sqm global-scale biopharmaceuticals manufacturing biotech complex in Aurangabad, India. The state-of-art complex comprises of six dedicated manufacturing facilities, designed according to USFDA and EMEA standards. In the complex, Wockhardt set up the first plant in Asia to manufacture its own recombinant DNA product.

Mott MacDonald provided services from plant scale up to process design and basic engineering, design and detailed engineering, construction supervision and project management on this prestigious 2200sqm - Asia's first recombinant protein project.

Customer Plaudit from Wockhardt for world class services rendered by Mott MacDonald

Oral solid and liquid dosage formulation plant – Himachal Pradesh, India


This plant is one of the largest formulation facility in India with an investment of USD 50 mn. Plant is designed to manufacture OSD, Tablets, Capsules, liquid orals and soft gelatine. The unit has a Pharma grade plant building of 225,000 sq. ft area.

Our role included concept development, engineering and tendering, site supervision and quality assurance services of this state of art pharmaceutical production facilities.


We rendered Concept Development, Complete Engineering, Tendering, Site Supervision, Construction Service Quality Assurance Services to Oral Solid and Liquid Dosage Formulation Plant, Baddi, Himachal Pradesh

Projects for Dr. Reddy’s laboratories


Mott MacDonald India is involved in setting up of various projects for Dr. Reddy’s Laboratories at various locations like Hyderabad, Vizag and Miryalguda. These plants were specially constructed to manufacture API and Bulk Drugs, Cyto toxic hormones, products for clinical trials.

Bacterial and mammalian cell fermentation plant


Scigen India Limited (Biopharmax India) set up this unit at Pune, India and appointed Mott MacDonald India for its extended basic engineering, detailed engineering, construction supervision and project management services. We worked on international technology as provided by client and prepared extended basic engineering document including cost estimates before taking up detailed engineering.

Research and Development Laboratory Project, Bangalore, Karnataka


Biocon, a global healthcare company, proposed to develop a research and development facility located at Bangalore in the state of Karnataka. The facility encompassed laboratories - bioassay, bio-analytical, characterization, formulation, analytical, cell culture, cell bank, microbial upstream / downstream, molecular biology, synthetic chemistry and process chemistry. Burt Hill Private Limited was appointed to provide architectural and civil engineering services. Mott MacDonald provided detailed engineering, procurement assistance and project management services for the facility on behalf of Burt Hill Private Limited.

Greenfield Formulation OSD Facility, Maharashtra


Mott MacDonald has been appointed by Flamingo Pharmaceuticals to provide engineering, procurement and construction management (EPCM) services for the development of two pharmaceutical formulation plants - Oral Solid Dosage (OSD) and betalactum facility in Nanded in the state of Maharashtra. The project development will include an OSD block, betalactum block, tank farms, effluent treatment plant, aboveground water storage, waste storage facility, storm water drain, an administrative building, sub-station as well as roads and a parking area.

API and Oral Solid Dosage (OSD) Facility, Gujarat


Torrent Pharmaceuticals manufactures API bulk drugs for speciality products and is a key player in cardiovascular, psychotropic and similar niche segments of healthcare. The manufacturing facility encompasses 25 molecules with a total capacity planned to produce 60 metric tonnes annually. The OSD formulation facility is planned to produce 3800 million tablets annually besides capsules and injectible. We provided basic and detailed engineering, master planning, conceptual design, detailed engineering, procurement assistance, construction supervision, commissioning assistance and project management services.

Greenfield Factory Project, Pune, Maharashtra


We are the engineering, procurement and construction management (EPCM) consultant for the Greenfield factory located near Pune in the state of Maharashtra for Shimizu Corporation.


© Mott MacDonald Group Limited 2012

Site by Mott MacDonald and Radley Yeldar ›